Drugmakers Bharat Biotech and GSK will cut the price of their malaria vaccine to below $5 per dose by 2028, more than halving its current cost, they said on Wednesday.

In a recent development, Bharat Biotech and GSK announced a price reduction of $5, which aims to improve access and save thousands of children who suffer from malaria.

GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine ...

Bharat Biotech and GSK announce price reduction for the world's first malaria vaccine to under $5. This move aims to improve access and save thousands of children in malaria-endemic countries.

Novartis and a Swiss nonprofit have made history, scoring the world’s first approval for a medicine to treat babies who are ...

The combination of climate change and pathogen expansion could be fueling a surge in infectious diseases. GEN consulted experts from academia and the biopharma industry to gather insights on the ...

Pharmalittle: We’re reading about chemo drugs failing quality tests, Gavi losing U.S. funding, and more ...

Imperial is one of twelve research organisations selected to deliver the Government’s £54 million fund to recruit the world’s top researchers.

Millions of children across the globe, including in Ghana, are set to receive life-saving vaccines against some of the world’s deadliest diseases, following a £1.25 billion pledge by the United ...

The manufacturers of the world’s first malaria vaccine are set to slash the price by more than half by 2028 to less than £4 per dose.